Jemal A, Siegel R, Ward E, et al. Cancer statistics[J]. CA Cancer J Clin, 2007, 57(1): 43-66.
[2]
Tannapfel A, Neid M, Aust D, et al. The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions[J]. Dtsch Arztebl Int, 2010, 107(43): 760-766.
[3]
Hiroshi K, Masao T, Hisashi S, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis[J]. Cancer, 2001, 91(11): 2026-2032.
[4]
Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis[J]. Am J Surg, 2006, 191(4): 517-526.
[5]
Rupnarain C, Dlamini Z, Naicker S, et al. Colon cancer: genomics and apoptotic events[J]. Biol Chem, 2004, 385(6): 449-464.
[6]
Watson AJM. An overview of apoptosis and the prevention of colorectal cancer[J]. Crit Rev Oncolo/Hematolo, 2006, 57(2): 107-121.
[7]
Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family [J]. Biochem Biophys Res Commun, 2000, 279(3): 820-831.
[8]
Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member [J]. J Biol Chem, 2001, 276(5): 3238-3246.
[9]
Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas [J]. Curr Biol, 2000, 10(21): 1359-1366.
[10]
Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene [J]. Oncogene, 2003, 22(51): 8330-8336.
[11]
Liu B, Han M, Wen JK, et al. Livin/ML-IAP as a new target for cancer treatment [J]. Cancer Letter, 2007, 250(2): 168-176.
[12]
Vucic D, Frankin MC, Walweber HJ, et al. Engineering ML-IA P to produce an extraordinarily potent Caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IA P [J]. Biochem J, 2005, 385(1): 11-20.
[13]
Nachmias B, Ashhab Y, Bucholtz V, et al. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor implication for drug-resistant melanoma [J]. Cancer Res, 2003, 63(10): 6340-6349.
